Osteoporosis, Postmenopausal
Showing 1 - 25 of 122
Osteoporosis, Postmenopausal Trial in Yantai (Denosumab)
Recruiting
- Osteoporosis, Postmenopausal
- Denosumab
-
Yantai, Shandong, ChinaShandong Boan Biotechnology Co., Ltd.
May 2, 2023
Cortical Bone Mechanics Technology Fracture Discrimination
Recruiting
- Osteoporosis
- +6 more
- Cortical Bone Mechanics Technology
-
Gainesville, Florida
- +4 more
Feb 7, 2023
Osteoporosis, Postmenopausal Trial in Port Saint Lucie (TVB-009, Prolia®)
Active, not recruiting
- Osteoporosis, Postmenopausal
- TVB-009
- Prolia®
-
Port Saint Lucie, FloridaSite 10101
Feb 1, 2023
Hypovitaminosis D, Osteoporosis, Postmenopausal, Menopause Trial in Mexico City (Cholecalciferol)
Completed
- Hypovitaminosis D
- +2 more
-
Mexico City, Gustavo A. Madero, MexicoPatricia Loranca-Moreno
Jan 24, 2023
Single or Repeat Zoledronate Versus Alendronate Following
Not yet recruiting
- Osteoporosis, Postmenopausal
- Zoledronate or Alendronate
-
Thessaloniki, Greece424 General Military Hospital
Jan 24, 2023
Osteoporosis, Postmenopausal Trial (early versus late biopsy)
Not yet recruiting
- Osteoporosis, Postmenopausal
- early versus late biopsy
- (no location specified)
Jan 9, 2023
Osteoporosis, Postmenopausal Trial (Zoledronate, Placebo)
Not yet recruiting
- Osteoporosis, Postmenopausal
- Zoledronate
- Placebo
- (no location specified)
Dec 15, 2022
Hip Fractures, Osteoporosis, Postmenopausal Trial in Hong Kong (AGN1 Femoral Local Osteo-Enhancement Procedure Kit)
Completed
- Hip Fractures
- Osteoporosis, Postmenopausal
- AGN1 Femoral Local Osteo-Enhancement Procedure Kit
-
Hong Kong, Hong KongQueen Mary Hospital - Department of Orthopaedics and Traumatolog
Nov 28, 2022
Zoledronic Acid to Prevent Bone Loss Following Denosumab
Recruiting
- Osteoporosis
- +3 more
- Zoledronic acid
-
Calgary, Alberta, CanadaUniversity of Calgary, McCaig Institute for Bone and Joint Healt
Nov 1, 2022
Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Cohort follow-up)
Recruiting
- Osteoporosis, Postmenopausal
- Cohort follow-up
-
Clermont-Ferrand, FranceCHU de Clermont-Ferrand
Oct 6, 2022
Osteoporosis, Postmenopausal Trial in Cairo (Calcium carbonate, Vitamin D3, laser acupuncture therapy)
Completed
- Osteoporosis, Postmenopausal
- Calcium carbonate
- +2 more
-
Cairo, EgyptKasr Alainy medical school
Sep 26, 2022
Primary Hyperparathyroidism, Osteoporosis, Postmenopausal Trial in Philadelphia
Active, not recruiting
- Primary Hyperparathyroidism
- Osteoporosis, Postmenopausal
-
Philadelphia, PennsylvaniaPerelman Center for Advanced Medicine/ Hospital of the Universit
Sep 22, 2022
Osteoporosis, Osteoporosis, Postmenopausal Trial in Sant Cugat Del Vallès (Focal Vibration, Control Group)
Not yet recruiting
- Osteoporosis
- Osteoporosis, Postmenopausal
- Focal Vibration
- Control Group
-
Sant Cugat Del Vallès, Barcelona, SpainUniversitat Internacional de Catalunya
Sep 13, 2022
Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures Trial in Pittsburgh (denosumab, Placebo, Calcium and Vitamin
Active, not recruiting
- Osteoporosis, Postmenopausal
- +2 more
- denosumab
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Senior Communities
Sep 7, 2022
Osteoporosis, Osteoporosis, Postmenopausal, Osteoporosis Fracture Trial in Pittsburgh (Romosozumab, Placebo, Zoledronic acid)
Recruiting
- Osteoporosis
- +2 more
- Romosozumab
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Senior Communities
Sep 7, 2022
Osteoporosis, Postmenopausal Trial (AVT03 (denosumab))
Recruiting
- Osteoporosis, Postmenopausal
- denosumab
-
Port Elizabeth, Gqeberha, South AfricaPHOENIX Pharma(Pty)Ltd
Sep 1, 2022
Osteoporosis, Postmenopausal Trial in Jaipur (Denosumab, Denosumab-Ref)
Recruiting
- Osteoporosis, Postmenopausal
-
Jaipur, Rajasthan, IndiaS. R. Kalla Memorial Gastro & General Hospital
Aug 16, 2022
Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)
Recruiting
- Osteoporosis, Postmenopausal
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Jackson, MississippiUniversity of Mississippi Medical Center
Aug 5, 2022
Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal Trial (Denosumab, Alendronate Sodium)
Not yet recruiting
- Nonalcoholic Fatty Liver
- Osteoporosis, Postmenopausal
- Denosumab
- Alendronate Sodium
- (no location specified)
Aug 6, 2022
Osteoporosis, Postmenopausal Trial in Copenhagen, Køge (Maltodextrin, Calcium-carbonate, Calcium-enriched permeate)
Active, not recruiting
- Osteoporosis, Postmenopausal
- Maltodextrin
- +3 more
-
Copenhagen, Frederiksberg, Denmark
- +1 more
Jul 22, 2022
Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Follow-up of patients with postmenopausal osteoporosis, with or without
Recruiting
- Osteoporosis, Postmenopausal
- Follow-up of patients with postmenopausal osteoporosis, with or without fractures, requiring initiation of injectable bisphosphonate therapy as part of their usual care
- Follow-up of patients with postmenopausal osteoporosis, fractured or not, requiring initiation of injectable bisphosphonate therapy as part of care with magnesium supplementation
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 29, 2022
Osteoporosis, Postmenopausal Trial in Ji'nan (EuBone ® capsule, )
Not yet recruiting
- Osteoporosis, Postmenopausal
- EuBone ® capsule
- placebo
-
Ji'nan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
May 30, 2022
Osteoporosis, Postmenopausal Trial in Kennesaw (Quercetin (500 mg), Placebo (500 mg))
Completed
- Osteoporosis, Postmenopausal
- Quercetin (500 mg)
- Placebo (500 mg)
-
Kennesaw, GeorgiaKennesaw State University
May 7, 2022
Osteoporosis, Postmenopausal, Type 2 Diabetes Trial in Seoul (Ibandronate Oral Tablet)
Completed
- Osteoporosis, Postmenopausal
- Type 2 Diabetes
- Ibandronate Oral Tablet
-
Seoul, Korea, Republic ofYeouido St.Mary's Hospital
Mar 2, 2022
Low Bone Mass, Osteoporosis, Postmenopausal Trial in Aurora (DHEA, Placebo, Exercise)
Recruiting
- Low Bone Mass
- Osteoporosis, Postmenopausal
- DHEA
- +2 more
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Feb 14, 2022